1. A cost-effectiveness analysis of vaccinating older adults with the 23-valent pneumococcal polysaccharide vaccine (PPV23) compared to no vaccination, the 13-valent pneumococcal conjugate vaccine (PCV13), or PCV13 followed by PPV23 in Colombia. (August 2018) Authors: Prieto, E.; Jiang, Y.; Yang, X.; Graham, J.B.; Monsanto, H.; Ruiz, J.; Beltrán, C.; Rojas, M. Journal: International journal of infectious diseases Issue: Volume 73(2018)Supplement Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗